Age and aging in blood disorders: multiple myeloma

Por Zweegman, Sonja, Palumbo, Antonio, Bringhen, Sara, Sonneveld, Pieter
Publicado em 2014

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

Por Engelhardt, Monika, Yong, Kwee, Bringhen, Sara, Wäsch, Ralph
Publicado no Haematologica (2019)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

Por Mattia D’Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Publicado em 2020-11-01

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

Por D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
Publicado no Int J Mol Sci (2020)

Emerging drugs and combinations to treat multiple myeloma

Por Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Publicado no Oncotarget (2017)

Approach to the Older Adult With Multiple Myeloma

Por Mina, Roberto, Bringhen, Sara, Wildes, Tanya M., Zweegman, Sonja, Rosko, Ashley E.
Publicado no Am Soc Clin Oncol Educ Book (2019)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Por Bonello, Francesca, Grasso, Mariella, D’Agostino, Mattia, Celeghini, Ivana, Castellino, Alessia, Boccadoro, Mario, Bringhen, Sara
Publicado no Pharmaceuticals (Basel) (2020)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

Por Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
Publicado no J Clin Med (2020)

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

Por Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
Publicado no Cancers (Basel) (2019)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

Por M Mateos, X Leleu, E Zamagni, M Delforge, S Bringhen, A Broijl, J de la Rubia, A Shaw, A Brescianini, S Gonzalez-McQuire, S Patel, P Moreau
Publicado em 2022-04-01

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

Por Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
Publicado no J Geriatr Oncol (2020)

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

Por Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola
Publicado em 2014

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

Por Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul
Publicado em 2010

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Por Facon, Thierry, Niesvizky, Ruben, Mateos, Maria-Victoria, Siegel, David, Rosenbaum, Cara, Bringhen, Sara, Weisel, Katja, Ho, P. Joy, Ludwig, Heinz, Kumar, Shaji, Wang, Kenneth, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Mezzi, Khalid, Goldrick, Amanda, Tekle, Christina, Dimopoulos, Meletios A.
Publicado no Blood Adv (2020)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-do...

Por Mateos, María-Victoria, Bringhen, Sara, Richardson, Paul G., Lahuerta, Juan Jose, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, García-Sanz, Ramón, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesús F., Palumbo, Antonio
Publicado em 2014

Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)...

Por Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika
Publicado no Haematologica (2018)

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies

Por Bringhen, Sara, Mina, Roberto, Petrucci, Maria Teresa, Gaidano, Gianluca, Ballanti, Stelvio, Musto, Pellegrino, Offidani, Massimo, Spada, Stefano, Benevolo, Giulia, Ponticelli, Elena, Galieni, Piero, Cavo, Michele, Di Toritto, Tommaso Caravita, Di Raimondo, Francesco, Montefusco, Vittorio, Palumbo, Antonio, Boccadoro, Mario, Larocca, Alessandra
Publicado no Haematologica (2019)

Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial

Por Dimopoulos, Meletios A., Špička, Ivan, Quach, Hang, Oriol, Albert, Hájek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, María-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar
Publicado no J Clin Oncol (2020)

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophospha...

Por Musto, Pellegrino, Simeon, Vittorio, Grossi, Alberto, Gay, Francesca, Bringhen, Sara, Larocca, Alessandra, Guariglia, Roberto, Pietrantuono, Giuseppe, Villani, Oreste, D’Arena, Giovanni, Cuomo, Carmela, Musto, Clelia, Morabito, Fortunato, Petrucci, Maria Teresa, Offidani, Massimo, Zamagni, Elena, Tacchetti, Paola, Conticello, Concetta, Milone, Giuseppe, Palumbo, Antonio, Cavo, Michele, Boccadoro, Mario
Publicado no Stem Cell Res Ther (2015)

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

Por McCarthy, Philip L., Holstein, Sarah A., Petrucci, Maria Teresa, Richardson, Paul G., Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D., Palumbo, Antonio, Attal, Michel
Publicado no J Clin Oncol (2017)